Please select the option that best describes you:
Do you perform biomarker-based screening for AL amyloidosis in patients with newly diagnosed MGUS?
If so, what is your approach to laboratory and clinical testing?
Answer from: Medical Oncologist at Academic Institution
No, unless the patient has signs and symptoms or imaging studies that suggest systemic Amyloidosis.
Sign in or Register to read more